XML 33 R13.htm IDEA: XBRL DOCUMENT v3.25.0.1
Investments
 12 Months Ended
Dec. 31, 2024
Investments, Debt and Equity Securities [Abstract]  
Investments Investments
The following table summarizes the Company’s investments in equity securities:
As of December 31,
20242023
$$
Equity securities with readily determinable fair values 1
  
Fair value of Leap common stock2,113 3,046 
Fair value of Leap warrants168 542 
Equity securities without readily determinable fair values
Pi Health, Inc. 2
40,798 — 
Other
48,157 55,860 
Equity-method investments
33,081 25,981 
Total124,317 85,429 
1 Represents common stock and warrants to purchase additional shares of common stock of Leap. The Company measures the investment in the common stock and warrants at fair value, with changes in fair value recorded to other (expense) income, net.
2 In the first quarter of 2024, the Company divested the net assets comprising substantially all of its Pi Health business with a carrying value of $38,063. The consideration received for the divestiture consisted of preferred stock in a newly formed entity, Pi Health, Inc., with a fair value of $40,798 and cash consideration of $1,000. The transaction resulted in a pre-tax gain of $3,735 recorded within other (expense) income, net during year ended December 31, 2024. The Company will account for its investment prospectively as a private equity security without a readily determinable fair value and the divestiture is not treated as a discontinued operation in the Statement of Operations and therefore the historical results of operations of the Pi Health business will remain in the Company’s continuing operations.
The following table summarizes unrealized (losses) gains related to investments in equity securities recorded in other (expense) income, net:
 Year Ended December 31,
 202420232022
 $$$
Equity securities with readily determinable fair values
(1,307)(425)(30,102)
Equity securities without readily determinable fair values(7,596)(6,448)5,065 
Equity-method investments
(10,275)(7,856)(3,682)